Lab test picks Cancer's poison in hope for tough myeloma cases
NCT ID NCT03389347
Summary
This study is testing a new, personalized method for treating multiple myeloma that has returned or stopped responding to standard drugs. Doctors take a sample of a patient's cancer cells and test many different drugs on them in the lab to see which ones work best. The goal is to use this 'matchmaking' test to help doctors and patients choose the most promising treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.